Curia Completes Acquisition Of Integrity Bio

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has completed the transaction to acquire Integrity Bio, Inc., a privately held formulation and fill-finish organization headquartered in Camarillo, California. The addition of Integrity Bio’s two California locations enhances Curia’s drug product formulation development capabilities and expands its fill-finish network, which also includes Curia’s three center-of-excellence facilities in Albuquerque, New Mexico; Burlington, Massachusetts and Glasgow, Scotland.